Esperion Therapeutics, Inc. (ESPR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
02-Aug-19 4:06 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 01-Aug-19Private Purchase 5,000$39.56$197,800.008%
66.16K to 71.16K
25-Jul-19 12:42 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 23-Jul-19Private Purchase 50,000$42.65$2,132,560.001%
3.52M to 3.57M
01-Jul-19 4:57 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 28-Jun-19Private Purchase 5,000$46.00$230,000.008%
61.16K to 66.16K
31-May-19 4:50 PM
View: 
Shepard Jay
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----100%
0 to 4.97K
31-May-19 4:52 PM
View: 
Woody Tracy M
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 9,934----100%
0 to 9.93K
31-May-19 6:09 PM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----60%
8.32K to 13.29K
31-May-19 4:52 PM
View: 
Berkowitz Jeffrey
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----100%
0 to 4.97K
31-May-19 4:52 PM
View: 
Braunstein Scott
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----9552%
52 to 5.02K
31-May-19 4:51 PM
View: 
Gotto Antonio M Jr Md D Phil
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----100%
0 to 4.97K
31-May-19 4:50 PM
View: 
McGovern Mark E
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----99%
5.0K to 9.97K
31-May-19 4:51 PM
View: 
Janney Daniel
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----20%
24.57K to 29.53K
05-Apr-19 5:23 PM
View: 
Bartram Richard
Chief Financial Officer
Esperion Therapeutics, Inc. (ESPR) 03-Apr-19Market Sale (Planned) 8,000$42.88$343,045.00259%
3.09K to 11.09K
(2%)
01-Apr-19 4:41 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 29-Mar-19Market Purchase 5,000$40.00$200,000.009%
56.16K to 61.16K
< 1%
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 21-Mar-19Acquisition (other) 1,356----5%
24.75K to 26.11K
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 21-Mar-19Disposition (other) 17,790----(68%)
26.11K to 8.32K
21-Mar-19 5:01 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 20-Mar-19Market Purchase 5,000$43.48$217,400.0010%
51.16K to 56.16K
< 1%
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 19-Mar-19Acquisition (other) 17,790----2%
1.12M to 1.14M
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 19-Mar-19Disposition (other) 1,101,080----(96%)
1.14M to 40.08K
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 19-Mar-19Market Sale 15,329$44.73$685,596.00(38%)
40.08K to 24.75K
15-Mar-19 7:50 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 14-Mar-19Market Purchase 50,000$49.89$2,494,360.001%
3.47M to 3.52M
(2%)
14-Mar-19 4:57 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 14-Mar-19Market Purchase 5,000$48.73$243,650.0011%
46.16K to 51.16K
10%
14-Mar-19 4:57 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 12-Mar-19Market Sale (Planned) 25,000$50.06$1,251,500.00(4%)
573.73K to 548.73K
(7%)
07-Jan-19 5:10 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 04-Jan-19Market Purchase 80,000$41.29$3,303,260.002%
3.39M to 3.47M
10%
26-Dec-18 11:44 AM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 24-Dec-18Market Purchase 50,000$39.91$1,995,720.001%
3.34M to 3.39M
14%
19-Dec-18 1:14 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 17-Dec-18Market Purchase 60,000$47.73$2,864,070.002%
3.28M to 3.34M
(5%)
05-Nov-18 7:56 PM
View: 
Boxer Capital, LLC
10% Owner
Esperion Therapeutics, Inc. (ESPR) 05-Nov-18Market Sale 60,000$57.16$3,429,840.00(5%)
1.16M to 1.1M
20%
02-Nov-18 5:00 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 02-Nov-18Market Sale (Planned) 227$50.76$11,522.50(< 1%)
573.95K to 573.73K
10%
05-Nov-18 7:56 PM
View: 
Boxer Capital, LLC
10% Owner
Esperion Therapeutics, Inc. (ESPR) 02-Nov-18Market Sale 40,000$55.21$2,208,500.00(3%)
1.2M to 1.16M
18%
02-Nov-18 5:00 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 01-Nov-18Market Sale (Planned) 2,600$50.01$130,026.00(< 1%)
576.55K to 573.95K
9%
18-Oct-18 5:05 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 18-Oct-18Market Sale (Planned) 100$50.00$5,000.00(< 1%)
576.65K to 576.55K
9%
18-Oct-18 5:05 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 17-Oct-18Market Sale (Planned) 12,673$50.02$633,903.00(2%)
589.33K to 576.65K
9%
18-Oct-18 5:05 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 16-Oct-18Market Sale (Planned) 9,400$50.01$470,094.00(2%)
598.73K to 589.33K
9%
29-Aug-18 4:56 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 27-Aug-18Market Sale (Planned) 17,700$51.05$903,610.00(3%)
616.43K to 598.73K
11%
22-Aug-18 7:18 AM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 17-Aug-18Market Sale (Planned) 7,300$50.06$365,438.00(1%)
623.73K to 616.43K
9%
06-Aug-18 3:23 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 03-Aug-18Market Purchase 50,000$46.14$2,306,970.002%
3.23M to 3.28M
(1%)
13-Jul-18 11:45 AM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 12-Jul-18Market Purchase 50,000$41.77$2,088,300.002%
3.18M to 3.23M
9%
03-Jul-18 11:55 AM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 29-Jun-18Market Purchase 50,000$39.48$1,973,800.002%
3.13M to 3.18M
15%
26-Jun-18 5:06 PM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 22-Jun-18Disposition (other) 21,471----(2%)
1.14M to 1.12M
26-Jun-18 5:06 PM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 22-Jun-18Acquisition (other) 3,846----< 1%
1.14M to 1.14M
25-Jun-18 12:43 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 21-Jun-18Market Purchase 60,000$38.57$2,314,220.002%
3.07M to 3.13M
18%
11-Jun-18 2:59 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 07-Jun-18Market Purchase 60,000$37.79$2,267,290.002%
3.01M to 3.07M
21%
08-Jun-18 5:08 PM
View: 
Goldstein Dov A Md
Director
Esperion Therapeutics, Inc. (ESPR) 06-Jun-18Option Exercise 13,000$16.47$214,100.0027660%
47 to 13.05K
08-Jun-18 5:08 PM
View: 
Goldstein Dov A Md
Director
Esperion Therapeutics, Inc. (ESPR) 06-Jun-18Disposition (other) 13,000----(100%)
13.05K to 47
07-Jun-18 2:34 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 05-Jun-18Market Purchase 60,000$38.47$2,308,440.002%
2.95M to 3.01M
18%
22-May-18 3:49 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 21-May-18Market Purchase 80,000$38.77$3,101,760.003%
2.87M to 2.95M
17%
22-May-18 3:49 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 18-May-18Market Purchase 50,000$42.24$2,112,010.002%
2.82M to 2.87M
8%
29-Mar-18 7:47 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 29-Mar-18Market Sale (Planned) 15,956$71.87$1,146,710.003%
616.81K to 632.77K
(37%)
29-Mar-18 7:47 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 29-Mar-18Market Sale (Planned) 9,044$73.26$662,563.00(1%)
632.77K to 623.73K
38%
31-May-19 4:51 PM
View: 
Janney Daniel
Director
Esperion Therapeutics, Inc. (ESPR) 28-Feb-18Acquisition (other) 24,565----100%
0 to 24.57K
09-Feb-18 5:47 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 07-Feb-18Option Exercise 34,651$6.99$242,210.006%
617.68K to 652.33K